Equities

Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)185.85
  • Today's Change-3.45 / -1.82%
  • Shares traded725.00
  • 1 Year change+64.47%
  • Beta0.7425
Data delayed at least 15 minutes, as of May 23 2024 10:54 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

  • Revenue in INR (TTM)303.45m
  • Net income in INR10.52m
  • Incorporated2012
  • Employees67.00
  • Location
    Arvee Laboratories (India) Ltd403, Entice Building,, Opposite JayantilBRTS Bus Stop,, Iskcon Bopal Road, AmblIAHMEDABAD 380058IndiaIND
  • Phone+91 2 717430479
  • Fax+91 7 926742600
  • Websitehttp://arveelabs.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jocil Ltd7.71bn31.65m1.72bn794.0054.37--18.640.22263.553.55867.83--------9,710,055.00--3.88--4.7720.5816.850.41061.50--1.14--22.0121.9921.4140.2519.482.824.56
Hindprakash Industries Ltd1.16bn30.02m1.72bn45.0053.80--47.791.482.792.79109.46------------5.09--7.578.027.632.582.79--2.13--26.36-2.732.91-9.721.2365.74--
Ducol Organics & Colours Ltd797.15m37.54m1.78bn74.0047.412.9631.652.232.582.5854.8741.350.99462.496.7310,772,260.004.68--7.00--32.51--4.71--0.72794.720.2396--10.25--76.94------
IVP Ltd5.79bn160.80m1.82bn202.0011.31--8.460.31415.5815.58561.07--------28,679,700.00--3.02--10.4918.8015.672.782.18--2.90--11.5018.7519.1258.9321.95-27.59-5.59
Srivasavi Adhesive Tapes Ltd686.77m45.87m1.97bn--38.216.2736.632.873.643.6455.0222.201.794.385.12--11.94--20.51--32.66--6.68--1.3323.070.0359---6.72--0.00------
Vital Chemtech Ltd1.06bn38.23m2.01bn46.0052.622.2833.011.891.591.5944.0836.690.92897.482.7423,020,740.003.35--5.19--18.90--3.61--3.224.250.2025--102.63--1.94------
Arvee Laboratories (India) Ltd303.45m10.52m2.09bn67.00197.197.1781.806.870.960.9627.8926.420.78572.703.30--2.726.663.4410.1251.2438.263.475.632.236.000.0332---50.54-11.18-74.46-14.2111.47--
Aksharchem (India) Ltd2.85bn-146.21m2.24bn169.00------0.7858-18.23-18.23356.47--------16,863,790.00--3.80--4.5438.9631.14-5.134.26---3.22--14.31-12.014.80-105.92---27.50-32.24
Data as of May 23 2024. Currency figures normalised to Arvee Laboratories (India) Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.